Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab

Int J Dermatol. 2017 May;56(5):571-572. doi: 10.1111/ijd.13565. Epub 2017 Feb 20.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Administration, Topical
  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy
  • Biopsy, Needle
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology*
  • Drug Therapy, Combination
  • Exanthema / chemically induced*
  • Exanthema / drug therapy
  • Exanthema / pathology*
  • Female
  • Follow-Up Studies
  • Histamine Antagonists / administration & dosage
  • Humans
  • Immunohistochemistry
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Histamine Antagonists
  • golimumab